SARS-CoV-2-IN-110
Product Specifications
Target
SARS-CoV
Related Pathways
Microbiology/Virology
Bioactivity
SARS-CoV-2-IN-110 (compound Bb1) is an inhibitor of SARS-CoV-2, demonstrating antiviral efficacy with an EC50 of 1.10 μM, and significantly reduced toxicity compared to Lapatinib. The compound exhibits a CC50 of greater than 100 μM against SARS-CoV-2, with a selectivity index (SI) exceeding 91.
Molecular Formula
C28H20ClFN4O2
Molecular Weight
498.94
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
GTR10467075 96 Well
Goat NADH ubiquinone oxidoreductase chain 4L (MT ND4L) ELISA kit
Sign In for Pricing
View Details 
22523141 1x 10^6 Cells / 1.0 mL
GPR157 CRISPR Knock Out 293T Cell Line (Human)
Sign In for Pricing
View Details